Strategic Expansion BioTechLogic joined Dark Horse Consulting Group in 2024, expanding its CMC consulting capacity and enabling access to clinical regulatory support, trial design, modeling, due diligence, and market evaluations. This presents a sales opportunity to offer integrated regulatory and market strategy services to current and prospective clients seeking end-to-end development support.

Integrated Offerings The combination of CMC, manufacturing, analytical, and regulatory resources with Dark Horse capabilities suggests a compelling value proposition for biotech and biopharma clients pursuing faster time to market through integrated consulting packages and bundled services.

Scale & Reach With an employee base of 11-50 and revenue in the mid to high hundreds of millions, BioTechLogic sits between boutique expertise and larger CROs. This positions it to target mid-market biotechs seeking specialized, flexible, high-quality CMC and regulatory support at competitive pricing.

Market Leadership A 20-year track record and a stated leadership position in biopharmaceutical CMC and manufacturing consulting indicate credibility and repeat business potential. Focus sales messaging on reliability, proven methodologies, and de-risked development journeys to win new clients facing regulatory complexity.

Digital & Outreach Readiness Existing tech stack elements like Google Ads Tracking, SEO tooling, and cloud infrastructure support scalable digital campaigns. Sales teams can leverage these signals to target biotech firms investing in CMC optimization, manufacturing efficiency, and regulatory readiness.